These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37784228)

  • 1. Rituximab induction and reinduction in granulomatosis with polyangiitis and microscopic polyangiitis: A retrospective multicenter study in Taiwan.
    Hsieh TY; Chen MH; Wu CC; Hong WJ; Lu CH; Lu CC; Lu LY; Hsieh SC; Tsai CY; Wu CS;
    Int J Rheum Dis; 2023 Dec; 26(12):2441-2449. PubMed ID: 37784228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator.
    Kwon HC; Kim MK; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2020 Aug; 61(8):712-719. PubMed ID: 32734735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
    Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
    Singh D; Sukumaran S
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis.
    Samson M; Devilliers H; Thietart S; Charles P; Pagnoux C; Cohen P; Karras A; Mouthon L; Terrier B; Puéchal X; Guillevin L
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36972927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
    Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS;
    Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
    Merkel PA; Niles JL; Mertz LE; Lehane PB; Pordeli P; Erblang F
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1372-1378. PubMed ID: 32475029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
    Jamois C; Gibiansky L; Chavanne C; Cheu M; Lehane PB; Pordeli P; Melega S; Gaudreault J
    Clin Transl Sci; 2022 Sep; 15(9):2172-2183. PubMed ID: 35765176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis.
    Iudici M; Quartier P; Terrier B; Mouthon L; Guillevin L; Puéchal X
    Orphanet J Rare Dis; 2016 Oct; 11(1):141. PubMed ID: 27770813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
    Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
    J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia is associated with decreased renal function and occurrence of end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study.
    Kwon HC; Ahn SS; Yoo BW; Yoo J; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2020 Jul; 40(7):1089-1099. PubMed ID: 32314011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis.
    Harigai M; Tsutsumino M; Takada H; Nagasaka K
    Korean J Intern Med; 2019 May; 34(3):492-503. PubMed ID: 30613065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cytokine targeted therapies for ANCA-associated vasculitis.
    Bala MM; Malecka-Massalska TJ; Koperny M; Zajac JF; Jarczewski JD; Szczeklik W
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008333. PubMed ID: 32990324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
    Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of chronic paranasal sinusitis for the classification of microscopic polyangiitis.
    Kwon HC; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Int J Clin Pract; 2020 Jan; 74(1):e13431. PubMed ID: 31573728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.